the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

View All Categories
View Conferences

Cancer Market Research Reports

 

Global Information, Inc. offers market intelligence on every topic in the Cancer Therapeutic/Diagnosis, including, but not limited to market trend on therapeutic of: Lung Cancer; Melanoma; Colorectal Cancer; Breast Cancer; Tumor; Cervical Cancer; Ovarian Cancer; Myeloma; Pancreatic Cancer and new Anticancer therapeutic like Immunotherapies; Angiogenesis Inhibitors; Protein Kinase Inhibitors.

We offer market research, industry forecasts, and business analysis in the Cancer Therapeutic/Diagnosis as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

 
 
Pipeline/Commercial Insight: Supportive Care in Oncology - Innovation and market growth limited to bone metastases management and emerging supportive care challenges
Table of Contents Published: 2009/11 Published by: Datamonitor
Supportive care in oncology is defined as those products used to prevent and/or treat the adverse side effects that arise as a result of the tumor itself or administration of anticancer therapies The supportive care market is potentially vast, therefore t ...

Prostate Cancer Drug Discoveries: what the future holds
Table of Contents Published: 2009/11 Published by: Espicom Business Intelligence
Prostate cancer (PCA) is the second leading cause of new cancer cases in men worldwide and the sixth leading cause of cancer death in men. In the US, over two million men currently suffer with PCA and it is estimated that there were 192,311 new cases and ...

Drug Delivery in Cancer - technologies, markets and companies
Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech
Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer. Cancer drug delivery is no longer sim ...

Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Table of Contents Published: 2009/10 Published by: BioSeeker Group AB
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of protein kinase dr ...

Innovations in Oncology Diagnostics: Technological advances, growth opportunities and future market outlook
Table of Contents Published: 2009/10 Published by: Business Insights
Despite public policy measures to prevent cancer, such as tobacco control and vaccination against HPV, cancer is sure to remain a significant public health problem throughout the 21st century. Indeed, the global demographic shift towards an ageing populat ...

Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine
Table of Contents Published: 2009/10 Published by: Datamonitor
CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there are 77 agents in development for ...

Global Skin Cancer Therapeutics Markets
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
This research service analyses the global skin cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. It also provides strategic recomme ...

Stakeholder Insight: Acute Leukemias - Reaching the limits of cytotoxic chemotherapy
Table of Contents Published: 2009/10 Published by: Datamonitor
The drug therapy of acute myeloid leukemia (AML) and adult acute lymphoblastic leukemia (ALL) is largely based on chemotherapy regimens that have changed little in the past few decades. Patient outcomes for both diseases remain poor, particularly for elde ...

Cancer Diagnostic Technologies: Assessment of Current and Emerging Technologies, and Their Potential Market Applications
Table of Contents Published: 2009/09 Published by: Venture Planning Group
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. A ...

Leading Cancer Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
Table of Contents Published: 2009/09 Published by: Venture Planning Group
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arra ...

Current and Emerging Cancer Diagnostic Tests: Emerging Assays and Companies Developing New Technologies and Products
Table of Contents Published: 2009/09 Published by: Venture Planning Group
The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hor ...

Cancer Diagnostic Testing: a Global Market Overview - Facilities, Test Volumes, and Sales Forecasts by Country
Table of Contents Published: 2009/09 Published by: Venture Planning Group
This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year ...

The US Cancer Diagnostics Market
Table of Contents Published: 2009/09 Published by: Venture Planning Group
This report presents a comprehensive analysis of the US cancer diagnostics market. ...

The UK Cancer Diagnostics Market
Table of Contents Published: 2009/09 Published by: Venture Planning Group
This report presents a comprehensive analysis of the UK cancer diagnostics market. ...

The Spanish Cancer Diagnostics Market
Table of Contents Published: 2009/09 Published by: Venture Planning Group
This report presents a comprehensive analysis of the Spanish cancer diagnostics market. ...

The Japanese Cancer Diagnostics Market
Table of Contents Published: 2009/09 Published by: Venture Planning Group
This report presents a comprehensive analysis of the Japanese cancer diagnostics market. ...

The Italian Cancer Diagnostics Market
Table of Contents Published: 2009/09 Published by: Venture Planning Group
This report presents a comprehensive analysis of the Italian cancer diagnostics market. ...

The German Cancer Diagnostics Market
Table of Contents Published: 2009/09 Published by: Venture Planning Group
This report presents a comprehensive analysis of the German cancer diagnostics market. ...

The French Cancer Diagnostics Market
Table of Contents Published: 2009/09 Published by: Venture Planning Group
This report presents a comprehensive analysis of the French cancer diagnostics market. ...

Forecast Insight: Top 20 Cancer Therapy Brands Targeted therapies will drive market growth in the wake of the cytotoxic and antihormonal patent cliff
Table of Contents Published: 2009/09 Published by: Datamonitor
The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer therapy sales totaled over $38 billion in the seven major pharmaceutical markets in ...

Chinese Markets for Bladder Cancer Treatment
Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co.
China' s demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry de ...

Chinese Markets for Brain Cancer Treatment Drugs
Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co.
China' s demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry deve ...

Chinese Markets for Cervical Cancer Treatment Drugs
Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co.
China' s demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry d ...

Chinese Markets for Colon Cancer Treatment Drugs
Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co.
China' s demand for Colon Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry deve ...

Chinese Markets for Anti-Tumor Drugs
Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co.
China' s demand for Anti-Tumor Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, sup ...

Competitor Analysis VEGF and VEGF-R Agonists and Antagonists
Table of Contents Published: 2009/09 Published by: La Merie
The present Competitive Intelligence Report about VEGF and VEGF-R agonists and antagonists provides a competitor evaluation in the field of VEGF and its receptor targeting molecules for treatment of cancer, AMD and for neuroprotection as of September 2009 ...

Molecular Targeted Cancer Therapies Market Forecast
Table of Contents Published: 2009/08 Published by: Datamonitor
Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key brands in these classes face imminent patent ...

Competitive Outlook on Lung Cancer Drug Development
Table of Contents Published: 2009/08 Published by: BioSeeker Group AB
This report includes defined and up to date development strategies for 283 lung cancer therapeutic drugs (>317 projects) within the portfolio of 167 investigators, from Ceased to Marketed. In total the report assesses three different sub-indications of lu ...

Chronic Myelogenous Leukemia: New Targeted Therapies Take Aim at Gleevec
Table of Contents Published: 2009/08 Published by: Decision Resources, Inc.
Chronic myelogenous leukemia (CML) is a rare blood cancer; nonetheless, CML treatments garner substantial revenues. Despite recent advances in the treatment of this disease (most notably, targeted therapeutics such as Novartis' s Gleevec/Glivec [imatinib] ...

Pipeline Insight: Prostate Cancer Molecular targeted therapies will fulfill unmet needs in castration-resistant disease
Table of Contents Published: 2009/08 Published by: Datamonitor
Incidence of prostate cancer in the seven major markets will be just over 422,000 in 2009, indicating high patient potential for drug developers to invest in. There are currently 136 agents in development for prostate cancer, two-thirds of which are novel ...

Commercial Insight: Molecular Targeted Cancer Therapies Leading companies will hold onto competitive advantage in high growth market
Table of Contents Published: 2009/08 Published by: Datamonitor
Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key brands in these classes face imminent patent ...

Launching Next Generation Oncology Products: Evolving Strategies in a Payor's Market
Table of Contents Published: 2009/08 Published by: Business Insights
1The emergence of a new wave of oncology products has been one of the most dramatic trends in the pharmaceutical market over the last decade. Both large and small companies are making unprecedented investments in oncology R&D, in an effort to emulate the ...

Antihormonal Therapies Market Forecast
Table of Contents Published: 2009/07 Published by: Datamonitor
Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. Collectively, the ...

Commercial Insight: Antihormonal Cancer Therapies - Stagnant sales indicative of a mature market
Table of Contents Published: 2009/07 Published by: Datamonitor
Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. ...

Competitor Analysis: PI3K-AKT-mTOR Inhibitors
Table of Contents Published: 2009/07 Published by: La Merie
The report includes a compilation of current active projects in research and development of PI3K-AKT-mTOR inhibitors in oncology and other indications. ...

Competitor Analysis: HDAC Inhibitors
Table of Contents Published: 2009/07 Published by: La Merie
The present Competitive Intelligence Report about HDAC Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting histone deacetylase for treatment of cancer and other diseases as of July 2009. ...

Lung Cancer Therapeutics
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the worldwide markets (Annual Revenues) for Lung Cancer Therapeutics in Millions of US$. The US market for Non-Small Cell Lung Cancer treatment is further analyzed by: Chemotherapy Drugs, and Targeted Drugs. ...

Brachytherapy
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the Global Market for Brachytherapy in Millions of US$. The eBrachytherapy' market is analyzed in terms of the following product segments: Implantable Prostate Seeds Brachytherapy, and Post-Operative Brachytherapy. Annual forecasts a ...

MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report
Table of Contents Published: 2009/07 Published by: Select Biosciences, Ltd.
This is the latest and most up-to-date Market Analysis Report from Select Biosciences addressing MicroRNA Diagnostics, Therapeutics and Cancer Personalized Medicine. The Cancer Personalized Medicine Marketplace Provides a Paradigm for the development of M ...

Colorectal Cancer Drug Discoveries: what the future holds
Table of Contents Published: 2009/07 Published by: Espicom Business Intelligence
The worldwide incidence of colorectal cancer (CRC) is approximately one million cases per year and, in the US, it is the third most common cancer in both sexes, accounting for around 8.5 per cent of all cancer deaths. ...

Lymphoma Drug Development Strategies at Work - Define Your Competition
Table of Contents Published: 2009/06 Published by: BioSeeker Group AB
This report includes defined and up to date development strategies for 176 lymphoma therapeutic drugs (>230 projects) within the portfolio of 106 investigators, from Ceased to Marketed. In total the report assesses five different sub-indications of lympho ...

Commercial Insight: Cytotoxic Therapies - Market growth will slow due to increasing genericization
Table of Contents Published: 2009/06 Published by: Datamonitor
The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs' success, generic entry will ensure continued ...

Cytotoxic Therapies Market Forecast
Table of Contents Published: 2009/06 Published by: Datamonitor
The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs' success, generic entry will ensure continued ...

Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
Table of Contents Published: 2009/06 Published by: CurrentPartnering, a division of Wildwood Ventures Limited
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies. The report provide ...

Chinese Markets for Leukemia Treatment Drugs
Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co.
China' s demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry developm ...

Monoclonal Antibodies in Cancer Therapy 2009-2024
Table of Contents Published: 2009/05 Published by: Visiongain
Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains. The oncology market continues to expand worldwide, with high demand for more-efficacious and better-tolerated cancer therapi ...

Therapeutic Peptides in Oncology - Favorable Conditions But Where to Commercialize?
Table of Contents Published: 2009/05 Published by: BioSeeker Group AB
The discovery of new cancer therapeutics has seen a significant shift towards biologicals as an alternative to small molecule drugs. Alternative binding peptide molecules, derived from combinatorial scaffold libraries, are now challenging traditional anti ...

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
Table of Contents Published: 2009/05 Published by: Kalorama Information
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics - focuses on several segments for cancer treatment. The report covers both currently marketed and late stage development cancer products. Revenues for each cur ...

Multiple Myeloma Therapeutics
Table of Contents Published: 2009/04 Published by: Global Industry Analysts, Inc.
This report analyzes the US market for Multiple Myeloma Therapeutics in Millions of US$. TThe market for multiple myeloma therapeutics is analyzed by the following Drugs: Thalomid, Revlimid, Velcade, and Others. The market for multiple myeloma therapeutic ...

Prostate Cancer Therapeutics
Table of Contents Published: 2009/04 Published by: Global Industry Analysts, Inc.
This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Millions. Analytics in the report specifically focuses on revenues generated from hormonal therapies.The report provides separate comprehensive analytics for US, Europe, an ...

Cancer Analysis
Published by: Espicom Business Intelligence
Cancer Intelligence Online is a new, daily-updated online business resource from Espicom. No other business intelligence service provides such current and extensive content. A subscription to Cancer Intelligence Online will save hours of research and make ...

EPiQ Market Intelligence Program: Pancreatic Cancer
Table of Contents Issues / Year: 2 Published by: WWMR, Inc.
The first and only pancreatic cancer market intelligence program to be based on the review of over 500 longitudinal patient charts. ...

Cancer Drug News
Issues / Year: 44 Published by: Espicom Business Intelligence
Cancer Drug News (CDN) can save you the time and effort of ensuring you have the necessary information to keep up-to-date with the developments in this world market. ...


US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.